Spots Global Cancer Trial Database for autologous chimeric antigen receptor t cell transfusing agent targeting cd22
Every month we try and update this database with for autologous chimeric antigen receptor t cell transfusing agent targeting cd22 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies | NCT03999697 | Diffuse Large B... Follicular Lymp... Primary Cutaneo... Extranodal Marg... Mantle Cell Lym... Plasma Cell Neo... B Cell Lymphoma | Autologous chim... | 3 Years - 70 Years | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
